| Ytd | -38.31% | |
| 1y | -65.61% |
| Open | 0.58 | Prev Close | 0.59 | Low | 0.58 | High | 0.62 | Mkt Cap | 4.59M |
| Vol | 12.35K | Avg Vol | 132.33K | EPS | -0.45 | P/E | -1.34 | Forward P/E | -0.47 |
| Beta | 2.06 | Short Ratio | 0.22 | Inst. Own | 5.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 0.67 | 200-d Avg | 0.90 | 1yr Est | 10.00 |
MBIO News
VANCOUVER, British Columbia, June 09, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include pa
This news release has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid
Vancouver, British Columbia – April 1, 2026 – TheNewswire - MindBio Therapeutics Corp. (CSE: MBIO);
Vancouver, British Columbia – TheNewswire - March 19, 2026 – MindBio Therapeutics Corp. (CSE: MBI
Mustang Bio (NASDAQ: MBIO - Get Free Report) and AstraZeneca (NASDAQ: AZN - Get Free Report) are bot
Vancouver, British Columbia - TheNewswire - February 18, 2026 – MindBio Therapeutics Corp. (CSE:
Vancouver, British Columbia – TheNewswire - February 18, 2026 – MindBio Therapeutics Corp. (CSE: MBI
Toronto, Ontario--(Newsfile Corp. - Le 4 novembre/November 2025) - MindBio Therapeutics Corp. has an
TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TS
Calidi Biotherapeutics (NYSE: CLDI) surged 39.47% after hours Tuesday, following renewed investor in
Mustang Bio surges 180% after its brain cancer therapy, MB-101, earns FDA Orphan Drug status for two
Mustang Bio shares are trading sharply higher Monday afternoon. The FDA granted Orphan Drug Designat
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 400 poin
Shares of Mustang Bio (NASDAQ: MBIO) surged on Monday as investors responded to a significant approv
In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patie
Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1082425
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1082425
WALTHAM, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (N
WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Na
WORCESTER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (
WORCESTER, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (
The company announced the pricing of a public offering of an aggregate of 2.66 million shares of its
WORCESTER, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (